Proteome Analysis of Hepatocellular Carcinoma by Two-dimensional Difference Gel Electrophoresis
Wei Sun(Beijing Proteome Research Center), Fuchu He(Beijing University of Technology), Xiaojuan Du(Peking University), Wei Mi(Peking University), Ying Jiang(Central South University), Chunyi Hao(Peking University), Xiaohong Qian(Ningbo Medical Center Lihuili Hospital), Yunping Zhu(Beijing Technology and Business University), Handong Wei(Beijing Proteome Research Center), Xueqin Gao(Steadman Philippon Research Institute), Baocai Xing(Ministry of Education), Songfeng Wu(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhuang Lu(Chinese Academy of Sciences), Min Lu(South China Agricultural University), Yi Sun(Peking University)
Cited by 247
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
|The Lancet Oncology|2023|436
Cyclin B1/Cdk1 Coordinates Mitochondrial Respiration for Cell-Cycle G2/M Progression
|Developmental Cell|2014|389